BioCentury | Apr 3, 2020
Deals

Janssen takes another shot at off-the-shelf CAR Ts with Fate deal

...race, the company was an early mover on allogeneic technologies. In 2014, it partnered with Transposagen Biopharmaceuticals Inc....
BioCentury | Jan 19, 2017
Emerging Company Profile

Piggyback CAR ride

...to piggyBac, Poseida has gene editing technology it obtained when it was spun out of Transposagen Biopharmaceuticals Inc....
...non-viral gene delivery platform Disease focus: Gene/cell therapy, Cancer Clinical status: Preclinical Founded: 2015 by Transposagen Biopharmaceuticals Inc....
...Santa Monica, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Poseida Therapeutics Inc., San Diego, Calif. Transposagen Biopharmaceuticals Inc....
BioCentury | Jun 15, 2015
Company News

Transposagen Biopharmaceuticals, J&J, Poseida Therapeutics deal

...own CAR T cell, CAR-NK and non-CAR T cell products (see BioCentury, Dec. 8, 2014). Transposagen Biopharmaceuticals Inc....
BioCentury | Dec 8, 2014
Company News

Transposagen Biopharmaceuticals, J&J deal

...cell therapies using NK or NK-like cells. The partners declined to disclose additional financial details. Transposagen Biopharmaceuticals Inc....
BioCentury | Nov 25, 2014
Company News

J&J, Transposagen partner to develop CAR T therapies

...The Janssen unit of Johnson & Johnson (NYSE:JNJ) and Transposagen Biopharmaceuticals Inc. (Lexington, Ky.) have started a three-year...
BioCentury | Jan 10, 2011
Company News

Cellular Dynamics, Transposagen Biopharmaceuticals deal

...of human-derived cells. Further terms were not disclosed. Cellular Dynamics International Inc. , Madison, Wis. Transposagen Biopharmaceuticals Inc....
BioCentury | Oct 25, 2010
Company News

Charles River, Transposagen Biopharmaceuticals Inc. sales and marketing update

...gene. Financial terms were not disclosed. Charles River Laboratories International Inc. (NYSE:CRL), Wilmington, Mass. Transposagen Biopharmaceuticals Inc....
Items per page:
1 - 7 of 7
BioCentury | Apr 3, 2020
Deals

Janssen takes another shot at off-the-shelf CAR Ts with Fate deal

...race, the company was an early mover on allogeneic technologies. In 2014, it partnered with Transposagen Biopharmaceuticals Inc....
BioCentury | Jan 19, 2017
Emerging Company Profile

Piggyback CAR ride

...to piggyBac, Poseida has gene editing technology it obtained when it was spun out of Transposagen Biopharmaceuticals Inc....
...non-viral gene delivery platform Disease focus: Gene/cell therapy, Cancer Clinical status: Preclinical Founded: 2015 by Transposagen Biopharmaceuticals Inc....
...Santa Monica, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Poseida Therapeutics Inc., San Diego, Calif. Transposagen Biopharmaceuticals Inc....
BioCentury | Jun 15, 2015
Company News

Transposagen Biopharmaceuticals, J&J, Poseida Therapeutics deal

...own CAR T cell, CAR-NK and non-CAR T cell products (see BioCentury, Dec. 8, 2014). Transposagen Biopharmaceuticals Inc....
BioCentury | Dec 8, 2014
Company News

Transposagen Biopharmaceuticals, J&J deal

...cell therapies using NK or NK-like cells. The partners declined to disclose additional financial details. Transposagen Biopharmaceuticals Inc....
BioCentury | Nov 25, 2014
Company News

J&J, Transposagen partner to develop CAR T therapies

...The Janssen unit of Johnson & Johnson (NYSE:JNJ) and Transposagen Biopharmaceuticals Inc. (Lexington, Ky.) have started a three-year...
BioCentury | Jan 10, 2011
Company News

Cellular Dynamics, Transposagen Biopharmaceuticals deal

...of human-derived cells. Further terms were not disclosed. Cellular Dynamics International Inc. , Madison, Wis. Transposagen Biopharmaceuticals Inc....
BioCentury | Oct 25, 2010
Company News

Charles River, Transposagen Biopharmaceuticals Inc. sales and marketing update

...gene. Financial terms were not disclosed. Charles River Laboratories International Inc. (NYSE:CRL), Wilmington, Mass. Transposagen Biopharmaceuticals Inc....
Items per page:
1 - 7 of 7